Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Ursino S, Calistri E, De Felice F, Bonomo P, Desideri I, Franco P, Arcadipane F, Colosimo C, Mazzola R, Maddalo M, Gonnelli A, Malfatti G, Morganti R, Musio D, Paiar F. Ursino S, et al. Among authors: gonnelli a. Dysphagia. 2023 Feb;38(1):159-170. doi: 10.1007/s00455-022-10434-4. Epub 2022 May 19. Dysphagia. 2023. PMID: 35587295 Free PMC article.
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
Laliscia C, Delishaj D, Fabrini MG, Gonnelli A, Morganti R, Perrone F, Tana R, Paiar F, Gadducci A. Laliscia C, et al. Among authors: gonnelli a. J Contemp Brachytherapy. 2016 Dec;8(6):512-517. doi: 10.5114/jcb.2016.64511. Epub 2016 Dec 9. J Contemp Brachytherapy. 2016. PMID: 28115957 Free PMC article.
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.
Pasqualetti F, Gonnelli A, Cantarella M, Delishaj D, Molinari A, Ortenzi V, Carbone F, Montrone S, Ursino S, Franceschi S, Morganti R, Orlandi P, Di Desidero T, Mazzanti CM, Zavaglia K, Naccarato AG, Bocci G, Paiar F. Pasqualetti F, et al. Among authors: gonnelli a. Invest New Drugs. 2018 Apr;36(2):340-345. doi: 10.1007/s10637-017-0516-2. Epub 2017 Sep 30. Invest New Drugs. 2018. PMID: 28965273
Image-guided Stereotactic Body Radiotherapy in Metastatic Prostate Cancer.
Pasqualetti F, Panichi M, Sainato A, Baldaccini D, Cocuzza P, Gonnelli A, Montrone S, Molinari A, Barbiero S, Bruschi A, Notini E, Ursino S, Mazzotti V, Morganti R, Coraggio G, Cantarella M, Erba PA, Paiar F. Pasqualetti F, et al. Among authors: gonnelli a. Anticancer Res. 2018 May;38(5):3119-3122. doi: 10.21873/anticanres.12572. Anticancer Res. 2018. PMID: 29715150
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Among authors: gonnelli a. Am J Clin Oncol. 2018 Dec;41(12):1272-1275. doi: 10.1097/COC.0000000000000464. Am J Clin Oncol. 2018. PMID: 29782366
Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration.
Pasqualetti F, Gonnelli A, Molinari A, Cantarella M, Montrone S, Cristaudo A, Baldaccini D, Mattioni R, Delishaj D, Mazzotti V, Morganti R, Cocuzza P, Fabrini MG, Lombardi G, Rudà R, Soffietti R, Paiar F. Pasqualetti F, et al. Among authors: gonnelli a. Anticancer Res. 2018 Oct;38(10):5877-5881. doi: 10.21873/anticanres.12930. Anticancer Res. 2018. PMID: 30275213
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?
Villani V, Fabi A, Tanzilli A, Pasqualetti F, Lombardi G, Vidiri A, Gonnelli A, Molinari A, Cantarella M, Bellu L, Terrenato I, Carosi M, Maschio M, Telera SM, Carapella CM, Cognetti F, Paiar F, Zagonel V, Pace A. Villani V, et al. Among authors: gonnelli a. Future Oncol. 2019 May;15(15):1717-1727. doi: 10.2217/fon-2018-0826. Epub 2019 Apr 12. Future Oncol. 2019. PMID: 30977687
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.
Pasqualetti F, Restante G, Gonnelli A, Rofi E, Molinari A, Crucitta S, Paiar F, Rudà R, Danesi R, Soffietti R, Del Re M. Pasqualetti F, et al. Among authors: gonnelli a. Neuro Oncol. 2019 Dec 17;21(12):1610-1611. doi: 10.1093/neuonc/noz157. Neuro Oncol. 2019. PMID: 31504796 Free PMC article. No abstract available.
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.
Pasqualetti F, Panichi M, Sollini M, Sainato A, Galli L, Morganti R, Chiacchio S, Marciano A, Zanca R, Mannelli L, Coraggio G, Sbrana A, Cocuzza P, Montrone S, Baldaccini D, Gonnelli A, Molinari A, Cantarella M, Mazzotti V, Ricci S, Paiar F, Erba PA. Pasqualetti F, et al. Among authors: gonnelli a. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):185-191. doi: 10.1007/s00259-019-04482-6. Epub 2019 Oct 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 31620808 Free PMC article.
75 results